LONDON – On Wednesday, AstraZeneca (NASDAQ: AZN) said its China president Leon Wang had been detained by Chinese authorities and, […]
AstraZeneca’s China Chief in Custody, Believes Arrest Unrelated to Insurance Probe Read More »
COPENHAGEN – Novo Nordisk (NYSE: NVO) is lifting curbs on prescriptions of its weight-loss drug Wegovy in the United States
Novo Nordisk Lifts Curbs on Wegovy Prescriptions in the US, CEO Says Read More »
On Tuesday, Novavax (NASDAQ: NVAX) said it has entered into a termination and settlement agreement with the UK Health Security
Novavax and UK Officially Terminate COVID-19 Vaccine Supply Contract Read More »
On Wednesday, Fresenius raised its full-year outlook after beating third-quarter expectations, citing strong performances at its Kabi and Helios divisions
Germany’s Fresenius Beats Q3 Estimates, Raises Full-Year Outlook Read More »
COPENHAGEN – On Wednesday, Novo Nordisk reported forecast-beating third-quarter sales of its popular Wegovy weight-loss drug, reassuring investors worried that
Novo Nordisk Stock Jumps as Q3 Wegovy Sales Top Estimates Read More »
LONDON – On Wednesday, Novo Nordisk (NYSE: NVO) chief financial officer Karsten Munk Knudsen said the company was aware of
Novo Nordisk is Aware of 10 Deaths From Compounded Weight-Loss Drug Copies Read More »
On Tuesday, AstraZeneca shares recorded their worst day since March 2020 after a report that dozens of the drugmaker’s senior
AstraZeneca Shares Slump on Report of Potential China Probe Fallout Read More »
On Monday, BioNTech (NASDAQ: BNTX), the German drugmaker, lowered its guidance for full-year revenue, citing COVID-19 uptake and price levels,
BioNTech Lowers 2024 Revenue Outlook on COVID-19 Seasonality and Inventory Write-downs Read More »
Americans are still eagerly seeking prescriptions for Eli Lilly’s (NYSE: LLY) and Novo Nordisk’s (NYSE: NVO) weight-loss and diabetes drugs
Americans Seeking Weight-Loss Drugs Face Supply and Insurance Hurdles Read More »
Copyright © 2024 abbonews.com
